📖 15 min read

ParkwayLife REIT 1Q 2026 Results: DPU Jumps 15.1% to 4.42¢

Singapore’s premier healthcare REIT resets its master lease — here’s what investors need to know

Key Numbers: DPU 4.42¢ (+15.1% YoY) | New SG Master Lease min rent ↑24.3% | Share price ~S$4.08 | Analyst target S$4.90 | SGX: C2PU

ParkwayLife REIT 1Q 2026 Results: DPU +15.1% YoY

ParkwayLife REIT (SGX: C2PU) — Singapore’s largest listed healthcare REIT — delivered a standout first quarter for FY2026, with distribution per unit (DPU) surging 15.1% year-on-year to 4.42 cents. The leap was powered by the reset of its Singapore master lease, which locked in a minimum rent increase of 24.3% to S$99.1 million per year through 2042.

For investors tracking S-REITs for passive income and long-term capital appreciation, ParkwayLife REIT’s 1Q 2026 results reinforce its reputation as a defensive, inflation-linked income asset. This guide breaks down the numbers, the lease dynamics, and what they mean for your portfolio.

What Is ParkwayLife REIT?

ParkwayLife REIT (C2PU) is Asia’s largest listed healthcare REIT by assets under management. Listed on the Singapore Exchange (SGX) in August 2007, it invests in income-producing real estate used for healthcare and healthcare-related purposes.

Key facts (as at 1Q 2026):

  • Portfolio: 60 properties across Singapore, Japan, and France
  • Singapore assets: 3 private hospitals (Mount Elizabeth, Gleneagles, Parkway East) leased to Parkway Hospitals Singapore (IHH Healthcare group)
  • Japan: 57 nursing homes and care facilities
  • France: 1 nursing home (Les Trois Forêts)
  • Total Assets Under Management: ~S$2.2 billion
  • Manager: Parkway Trust Management Limited (subsidiary of IHH Healthcare)

Its Singapore portfolio generates the majority of distributable income, and the Singapore Master Lease — a long-term contract with IHH — is the cornerstone of its stability. The 2026 lease reset is therefore a pivotal event for unitholders.

1Q 2026 Financial Results at a Glance

ParkwayLife REIT released its 1Q FY2026 Business Update in May 2026. Here are the headline numbers:

Metric 1Q FY2025 1Q FY2026 Change
Gross Revenue S$39.0M S$38.2M −2.1%
Net Property Income (NPI) S$36.8M S$35.8M −2.7%
Distributable Income S$19.5M S$27.5M +41.0%
DPU 3.841¢ 4.42¢ +15.1%

Source: ParkwayLife REIT 1QFY2026 Business Update. All figures in SGD.

While gross revenue and NPI dipped modestly (partly due to JPY weakness affecting Japan portfolio income), distributable income surged 41% on the strength of the higher Singapore Master Lease rent — a structural improvement, not a one-off.

DPU Breakdown and Yield Analysis

The DPU of 4.42 cents for 1Q FY2026 represents the highest quarterly distribution ParkwayLife REIT has paid since its listing. At the current share price of approximately S$4.08, the annualised metrics look like this:

Metric Value
1Q 2026 DPU 4.42¢
Annualised DPU (2026F) ~17.7¢
Share Price (approx.) S$4.08
Forward Dividend Yield ~4.3–4.4%
Analyst Target Price S$4.90
Implied Upside ~20%

Compared to the broader S-REIT universe — which averages 5–7% yield — ParkwayLife trades at a premium due to its defensive healthcare exposure, long WALE (weighted average lease expiry), and inflation-linked income structure. Investors pay for quality and predictability.

The Singapore Master Lease Reset: What It Means

The biggest catalyst for ParkwayLife REIT’s improved distributions in 2026 is the renewal and reset of its Singapore Master Lease, which governs the three Singapore hospital properties.

Key terms of the new Singapore Master Lease (effective 2026):

  • Lease term: 2026 to 2042 (16 years)
  • New minimum base rent: S$99.1 million per year
  • Increase vs. prior lease: +24.3%
  • Escalation: Linked to Singapore CPI with downside protection (minimum guaranteed rent)
  • Lessee: Parkway Hospitals Singapore Pte Ltd (100% owned by IHH Healthcare — one of Asia’s largest private hospital operators)

This lease structure provides exceptional income visibility. Unlike retail or commercial REITs exposed to occupancy risk, ParkwayLife’s Singapore income is contractually guaranteed for 16 years. The CPI-linkage means distributions grow with inflation — a key differentiator in rising-rate environments.

The reset to S$99.1M minimum rent essentially locked in the 15%+ DPU improvement permanently for the duration of the lease, barring any extraordinary events with IHH.

Key Charts: Financials & DPU Trend

ParkwayLife REIT 1Q 2026 vs 1Q 2025 key financials comparison chart
ParkwayLife REIT quarterly DPU trend 1Q 2025 to 1Q 2026 and Singapore master lease impact

Portfolio Overview: Singapore, Japan & France

ParkwayLife REIT’s geographic diversification provides resilience, though Singapore remains the dominant income contributor:

Geography Properties Asset Type % Revenue
Singapore 3 Private hospitals ~70%
Japan 56 Nursing homes / aged care ~29%
France 1 Nursing home ~1%

Japan portfolio note: The Japan assets are leased on master lease structures (similar to Singapore) with CPI-linked escalation. A weakening JPY has been a headwind in 2025–2026, softening JPY-denominated income when converted to SGD. However, JPY-hedging and long WALE leases mitigate this. The Japan portfolio adds aging-population demographic tailwinds as a long-term growth driver.

Investment View: Is ParkwayLife REIT Worth Buying?

ParkwayLife REIT is not a high-yield REIT — its ~4.3% forward yield lags the sector average. But it compensates with something most S-REITs cannot offer: near-certainty of income growth.

Bull case:

  • New Singapore lease locked in for 16 years at +24.3% minimum rent — structural DPU step-up, not a temporary blip
  • CPI escalation clause means distributions grow with inflation
  • IHH Healthcare (AAA-credit quality tenant) eliminates default risk on 70% of income
  • Aging population in Japan and Singapore drives long-term demand for healthcare facilities
  • Analysts have target price of S$4.90 vs. ~S$4.08 current price — ~20% upside potential

Bear case / risks:

  • JPY weakness compresses Japan income in SGD terms
  • Premium valuation (lower yield vs. peers) limits margin of safety
  • Any IHH credit event would directly impact ~70% of revenue (concentration risk)
  • Rising interest rates increase cost of debt (though ~90% fixed-rate debt provides near-term buffer)

TKN view: For investors seeking defensive income with inflation protection and long income visibility, ParkwayLife REIT is one of Singapore’s highest-quality REITs. It suits a conservative or core allocation — not a yield-maximiser play, but a compounder with downside protection.

Compare it with other best REITs in Singapore 2026 to see where it fits in a diversified REIT portfolio.

How to Invest in ParkwayLife REIT in Singapore

ParkwayLife REIT (C2PU) is listed on SGX and can be purchased through any Singapore brokerage. Here are our top platforms for S-REIT investors:

Platform Best For SGX Fees
moomoo Low-cost SGX trading From 0.03%
Endowus CPF/SRS investing + managed portfolios 0.3–0.4% p.a. platform fee
Syfe REIT+ managed portfolio 0.35–0.65% p.a. platform fee
FSMOne Low commission SGX stocks 0.08%, min S$10

Want to save on fees? Use our exclusive referral codes:

Frequently Asked Questions

What is ParkwayLife REIT's DPU for 1Q 2026?
ParkwayLife REIT declared a DPU of 4.42 cents for 1Q FY2026, up 15.1% year-on-year from 3.841 cents in 1Q FY2025. This was driven by the new Singapore Master Lease, which increased minimum annual rent by 24.3% to S$99.1 million per year.
Why did ParkwayLife REIT's DPU jump so much in 2026?
The primary driver was the reset of ParkwayLife REIT’s Singapore Master Lease with Parkway Hospitals Singapore (IHH Healthcare subsidiary). The new lease runs from 2026 to 2042 with a minimum base rent of S$99.1 million per year — a 24.3% increase over the previous lease. Since Singapore generates ~70% of revenue, this structural uplift flowed directly into distributable income and DPU.
What is ParkwayLife REIT's dividend yield in 2026?
Based on a 1Q 2026 DPU of 4.42 cents and an annualised estimate of ~17.7 cents, ParkwayLife REIT’s forward dividend yield is approximately 4.3–4.4% at a share price of ~S$4.08. This is below the S-REIT average of 5–7%, reflecting its premium quality and defensive income profile.
Is ParkwayLife REIT a good long-term investment?
ParkwayLife REIT is widely regarded as one of Singapore’s highest-quality REITs. Its long-term lease with IHH Healthcare (16-year new lease to 2042), CPI-linked income escalation, and diversified healthcare property portfolio make it a strong defensive compounder. Analyst consensus target price of ~S$4.90 implies ~20% upside from current levels. It suits conservative investors seeking inflation-protected income rather than maximum yield.
How can I buy ParkwayLife REIT (C2PU) in Singapore?
ParkwayLife REIT is listed on SGX under ticker C2PU. You can buy it through any Singapore brokerage such as moomoo, FSMOne, DBS Vickers, or UOB Kay Hian. For CPF or SRS investing, platforms like Endowus allow you to invest in REIT-focused portfolios using your CPF savings.
What are the risks of investing in ParkwayLife REIT?
Key risks include: (1) JPY currency risk from Japan portfolio (~29% of revenue); (2) Concentration risk — ~70% of income depends on IHH Healthcare; (3) Premium valuation with lower-than-average yield; (4) Interest rate risk affecting borrowing costs. However, ~90% fixed-rate debt and long WALEs substantially mitigate these risks.

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every week.

We don’t spam! Read our privacy policy for more info.

This article was researched with the help of AI. While we strive to keep all information accurate and up to date, there may be errors. If you notice any discrepancies, please contact us.